Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Hydrix Limited (HYD.AX)
Mulgrave, VIC, AU
Hydrix Limited, together with its subsidiaries, operates as a product design and engineering company in Australia, Europe, North America, Singapore, and internationally. It operates in three segments: Hydrix Services, Hydrix Medical, and Hydrix Ventures. The company offers product design and development consulting services comprising systems engineering, software, electronics, mechanical, human factors, and industrial design services; and product consulting services consisting of engineering design, development, prototyping, manufacturer management, and certification process management services. It also distributes cardiovascular products comprising Guardian, a heart attack warning system; and Implicity, a cloud-based AI-driven remote cardiac patient monitoring and data management software. In addition, the company invests in early stage medical technology (medtech) companies. It serves the cardiovascular, medtech, defence, and industrial industries. The company was formerly known as Panorama Synergy Limited and changed its name to Hydrix Limited in November 2018. Hydrix Limited was incorporated in 1993 and is based in Mulgrave, Australia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -53.85% | +128.52% | -64.71% | -60.00% | -50.00% | -57.14% | -77.78% | -96.02% | -99.46% | -99.85% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Software - Application: +13.0%-4.9% Q4'25: -18.1% (vs Q4'23)
-
EPS growth Software - Application: +28.6%+69.4% ★ Q4'25: +42.3% (vs Q4'23)
-
FCF margin FCF growth · Software - Application: +45.3%-24.4% Q4'25: -4.4% (vs Q4'23)
-
EBIT margin Software - Application: +9.4%-18.0% Q4'25: -28.3% (vs Q4'23)
-
ROIC Software - Application: +7.5%-109.8% Q4'25: -856.7% (vs Q4'23)
-
Share dilution Software - Application: +0.0%-0.2% ★ Q4'25: +7.3% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×-5.71× Q4'25: -2.35× (vs Q4'23)
| Metric |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 1 Rev. Ana. |
Jun 2027 1 Rev. Ana. |
|---|---|---|---|---|---|
| Revenue |
13.16M
est: 14.41M (-8.7%)
|
10.61M
est: 10.60M (+0.1%)
|
10.09M
est: 19.14M (-47.3%)
|
22.22M
22.22M – 22.22M
+16.1% YoY
|
25.58M
25.58M – 25.58M
+15.2% YoY
|
| EBITDA |
1.30M
est: -5.85M (+122.2%)
|
-7.92M
est: -4.30M (-84.0%)
|
-1.40M
est: -7.77M (+82.0%)
|
-9.02M
-9.02M – -9.02M
-16.1% YoY
|
-10.38M
-10.38M – -10.38M
-15.2% YoY
|
| EBIT |
-18.8K
est: -7.26M (+99.7%)
|
-8.86M
est: -5.34M (-65.8%)
|
-1.81M
est: -9.65M (+81.2%)
|
-11.20M
-11.20M – -11.20M
-16.1% YoY
|
-12.89M
-12.89M – -12.89M
-15.2% YoY
|
| Net Income |
-396.9K
|
-9.56M
|
-2.92M
|
—
— – —
|
—
— – —
|
| SGA |
12.43M
est: 15.88M (-21.7%)
|
11.23M
est: 11.68M (-3.8%)
|
9.32M
est: 21.09M (-55.8%)
|
24.47M
24.47M – 24.47M
+16.1% YoY
|
28.18M
28.18M – 28.18M
+15.2% YoY
|
| EPS |
0.00
|
-0.04
|
-0.01
|
—
— – —
|
—
— – —
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gavin Coote | Executive Chairman | 358.6K | male |
| Peter R. Lewis | Executive Vice President of Business Development | 290.9K | male |
| Gareth Evans | Chief Financial Officer | 281.1K | male |
| Alyn Tai | Corporate Counsel & Company Secretary | — | female |
| Alan Morris | Group Marketing Director | — | male |
| John Bumgarner | Chief Research Officer | — | — |
| Robert Brierley | Director of Human Resource | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HYD.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
